Evidence map›Paper›PMID 31856157›Full record

ReviewPLoS neglected tropical diseases2019

Gene drives for schistosomiasis transmission control.

Theresa Maier, Nicolas James Wheeler, Erica K O Namigai, Josh Tycko, Richard Ernest Grewelle, Yimtubezinash Woldeamanuel, Katharina Klohe, Javier Perez-Saez, Susanne H Sokolow, Giulio A De Leo and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. CRISPR/Cas9-germline editing ofScience advances · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Accelerating snail vector genomics.Infectious diseases of poverty · 2024
    Article
  8. Article
  9. Article
  10. The genome and transcriptome of the snailbioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. PeerJ · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 5 countries.

Theresa MaierDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Nicolas James WheelerDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Erica K O NamigaiDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Josh TyckoDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Richard Ernest GrewelleHopkins Marine Station, School of Humanities and Sciences, Stanford University, Pacific Grove, California, United States of America.
Yimtubezinash WoldeamanuelDepartment of Microbiology, Immunology & Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0001-6606-8903
Katharina KloheGlobal Schistosomiasis Alliance, Munich, Germany.
Javier Perez-SaezLaboratory of Ecohydrology, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Susanne H SokolowWoods Institute for the Environment, Stanford University, Stanford, California, United States of America.
Giulio A De LeoHopkins Marine Station, School of Humanities and Sciences, Stanford University, Pacific Grove, California, United States of America.
Timothy P YoshinoDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Mostafa ZamanianDepartment of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.ORCID 0000-0001-9233-1760
Jutta Reinhard-RuppGlobal Health Institute of Merck (KGaA), Eysins, Switzerland.
University of Wisconsin–Madison · USPacific University · USAddis Ababa University · ETÉcole Polytechnique Fédérale de Lausanne · CHMerck Serono (Switzerland) · CHMunich Security Conference · DEStanford University · USUniversity of California, Santa Barbara · USUniversity of Cambridge · GBUniversity of Oxford · GB

Funding

Effects of agricultural expansion and intensification on infectionsR01TW010286 · FIC · UNIVERSITY OF SOUTH FLORIDA · PI REMAIS, JUSTIN V, ROHR, JASON ROBERT · 2015 to 2019
$2.4M
Uncovering new mechanisms of nematode anthelmintic resistanceK22AI125473 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ZAMANIAN, MOSTAFA · 2017 to 2018
$269k
FIC NIH HHS R01 TW010286NIAID NIH HHS K22 AI125473
6 · The paper itself

Abstract

Schistosomiasis is one of the most important and widespread neglected tropical diseases (NTD), with over 200 million people infected in more than 70 countries; the disease has nearly 800 million people at risk in endemic areas. Although mass drug administration is a cost-effective approach to reduce occurrence, extent, and severity of the disease, it does not provide protection to subsequent reinfection. Interventions that target the parasites' intermediate snail hosts are a crucial part of the integrated strategy required to move toward disease elimination. The recent revolution in gene drive technology naturally leads to questions about whether gene drives could be used to efficiently spread schistosome resistance traits in a population of snails and whether gene drives have the potential to contribute to reduced disease transmission in the long run. Responsible implementation of gene drives will require solutions to complex challenges spanning multiple disciplines, from biology to policy. This Review Article presents collected perspectives from practitioners of global health, genome engineering, epidemiology, and snail/schistosome biology and outlines strategies for responsible gene drive technology development, impact measurements of gene drives for schistosomiasis control, and gene drive governance. Success in this arena is a function of many factors, including gene-editing specificity and efficiency, the level of resistance conferred by the gene drive, how fast gene drives may spread in a metapopulation over a complex landscape, ecological sustainability, social equity, and, ultimately, the reduction of infection prevalence in humans. With combined efforts from across the broad global health community, gene drives for schistosomiasis control could fortify our defenses against this devastating disease in the future.

Indexed as

Disease ReservoirsDisease ResistanceAnimalsDisease Transmission, InfectiousGene Drive TechnologyHumansSchistosomiasisSnails

Identifiers

PMID31856157
PMCPMC6922350
OpenAlexW2995712673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.